Medika Life

1 week ago | medika.life | Gil Bashe

I was in the media bullpen with the team when the future arrived. The launch of Roferon-A, alpha interferon marked a watershed moment in medicine: the first biotherapeutic to treat cancer, targeting the rare disease . I remember the packed press conference at The Pierre Hotel in New York City. Thought leaders like Dr. Jerome Groopman inspired awe. Headlines followed. The world paid attention. That was decades ago.

2 weeks ago | medika.life | Gil Bashe

When I first encountered Yasushi Yamamoto—musician, philosopher, investor, and Founder and CEO of Corundum—I was struck by how naturally he speaks of Renaissance ideals while steering a 21st-century venture fund. Yamamoto-san founded Corundum on the conviction that tomorrow’s most important medical solutions will be born only when deep science melds with art, philosophy, and finance and we see the connection between biology and technology. That conviction and voice found a physical home.

2 weeks ago | medika.life | Gil Bashe

There’s a truth in health innovation: “Where data meets intent, change follows.” The latest Galen Growth report—FemTech 2.0: Doubling Down on Growth—is not just another data drop into the expanding ocean of digital health statistics. It’s a clarion call, a meticulously mapped road forward. It tells us that the investment conversation around FemTech is evolving from app hype and pink-washed branding to clinical reality, infrastructure integration, equitable access and a vision for ROI.

1 month ago | medika.life | John Nosta

Healthcare is in constant motion—bending to social pressures, economic realities, and technological breakthroughs. But if we step back and observe the arc of medical care over the past century, an interesting path emerges. What began as deeply personal evolved into a system dominated by an often reckless drive for efficiency, metrics, and third-party bureaucrats. And now, in an unexpected twist, we may be witnessing a return—not to the past, but to something re-humanized.

1 month ago | medika.life | Gil Bashe

“Branding is a matter of building trust and committing to a level of quality and service. It is an emotional connection that transcends the actual product.”—Gil Bashe, “Global Marketing Strategies” and “Emotion: The New Brand Integrator,” Pharmaceutical Executive, 2000Twenty-five years ago, in a series of articles for Pharmaceutical Executive that may have seemed radical at the time, I argued that successful marketing wasn’t built on features but feelings. Back then, people were skeptical.